Travere Therapeutics, Inc.
TVTX· Nasdaq
TVTXTravere Therapeutics, Inc.
Filed Aug 8, 2012 · 10-Q · 69 days after period end · 0001225279-12-000193
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Net Income | -$3.51K | -$3.52K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Travere Therapeutics, Inc. · CIK 1438533 · Engraved from SEC EDGAR
ended May 31, 2012 · filed Aug 8, 2012 · 69 d after period end
